We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in conjunction with Avalo’s recent acquisition of...
Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront...
Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed...
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split of the Company’s common stock, par value...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.51 | -17.0054200542 | 14.76 | 18.79 | 12 | 134955 | 15.15925301 | CS |
4 | 7.78 | 174.049217002 | 4.47 | 34.46 | 4.43 | 2111863 | 19.75684291 | CS |
12 | 7.88 | 180.320366133 | 4.37 | 34.46 | 4.0101 | 712064 | 19.33305724 | CS |
26 | -25.694 | -67.715580856 | 37.944 | 38.04 | 3.9501 | 12843160 | 19.472287 | CS |
52 | -710.15 | -98.3042635659 | 722.4 | 1130.4 | 3.9501 | 23584955 | 33.39772522 | CS |
156 | -676.55 | -98.2215447154 | 688.8 | 1711.2 | 3.9501 | 9056369 | 39.32301895 | CS |
260 | -676.55 | -98.2215447154 | 688.8 | 1711.2 | 3.9501 | 9056369 | 39.32301895 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions